In this review, we discuss the emerging evidence that miRs have a role in reducing AMPK activity in NAFLD and nonalcoholic steatohepatitis (NASH), a severe form of NAFLD. Here, PRKAA2 is linked to metabolic dysfunction-associated steatohepatitis.